Table 2. Univariable and multivariable analyses for poor outcome at 3 months (mRS 3–6).
Univariable | Multivariable | |||
---|---|---|---|---|
HR (95% CI) | p-value | HR (95% CI) | p-value | |
Age (years) | ||||
<65 | 1 | |||
≥65 | 1.20 (0.83–1.74) | 0.342 | 1.12 (0.69–1.80) | 0.649 |
Sex (men) | 0.89 (0.60–1.31) | 0.544 | 1.21 (0.75–1.97) | 0.438 |
Hypertension | 1.63 (1.02–2.61) | 0.041 | 1.52 (0.86–2.68) | 0.149 |
Diabetes | 1.10 (0.76–1.60) | 0.616 | ||
Hyperlipidemia | 1.11 (0.64–1.91) | 0.720 | ||
Smoking | 0.94 (0.65–1.36) | 0.751 | ||
Pulse pressure (mmHg) | 1.00 (1.00–1.01) | 0.415 | ||
Total cholesterol (mmol/L) | 1.13 (0.93–1.37) | 0.213 | ||
Triglyceride (mmol/L) | 0.78 (0.60–1.01) | 0.057 | 0.82 (0.62–1.10) | 0.190 |
HDL (mmol/L) | 1.54 (0.95–2.48) | 0.078 | 1.67 (0.95–2.93) | 0.076 |
LDL (mmol/L) | 1.03 (0.86–1.23) | 0.789 | ||
Serum creatinine (μmol/L) | 0.96 (0.69–1.33) | 0.791 | ||
Initial NIHSS score | ||||
0–2 | 1 | 1 | ||
3–5 | 6.02 (2.75–13.17) | <0.001 | 6.08 (2.75–13.48) | <0.001 |
≥6 | 30.39 (14.74–62.66) | <0.001 | 30.95 (14.82–64.66) | <0.001 |
Previous antithrombotics | 1.11 (0.56–2.20) | 0.773 | ||
Previous statin | 1.15 (0.48–2.74) | 0.756 | ||
Severe WMH | 1.23 (0.85–1.78) | 0.265 | 1.17 (0.73–1.86) | 0.525 |
Data are expressed as the hazard ratio (95% CI);
HDL, high density lipoprotein; LDL, Low density lipoprotein; NIHSS, National Institute of Health Stroke Scale; WMH, white matter hyperintensity.